Dynamics of eligibility criteria for central nervous system metastases in non-small cell lung cancer randomized clinical trials over time: A systematic review

J.J.A.O. Schoenmaekers, S. Dursun, C. Biesmans, D.K.M. De Ruysscher, M.P.G. Broen, J. Remon, A.M.C. Dingemans, L.E.L. Lucia*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number103460
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume166
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • NSCLC
  • Brain metastases
  • Screening
  • Eligibility
  • Clinical trials
  • QUALITY-OF-LIFE
  • BRAIN METASTASES
  • OPEN-LABEL
  • RESPONSE ASSESSMENT
  • SOLID TUMORS
  • J-ALEX
  • CRIZOTINIB
  • CHEMOTHERAPY
  • ALECTINIB
  • EFFICACY

Cite this